We are developing new technology that enables point-of-care, germ-specific diagnosis and antibiograms, in a fraction of current cost, time and infrastructure. While doctors can often diagnose infectious diseases clinically, there are no tools to easily identify the microorganism underlying each case: this leads to the overprescription of broad-spectrum antibiotics, contributing to antimicrobial resistance –a global emergency, projected to become the first cause of death by 2050, surpassing cancer! We received seed funding and opened a lab with very promising results, and are now pursuing our Series A.
Company Details
- Employees
- 2
- Founded
- -
- Address
- 75 Kneeland St,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Biotechnology, Diagnostics, Translational medicine, Bacterial identification, Viral identification, Fungal identification, Microbial quantification, Antibiogram, Electronics, Robotics.
- HQ
- Boston, Massachusetts
Oxbridge Clinical Questions
Oxbridge Clinical's website is https://www.oxbridgeclinical.com/
Oxbridge Clinical's LinkedIn profile is https://www.linkedin.com/company/oxbridge-clinical
Oxbridge Clinical has
2 employees.
View email and phone details for 2
employees at Oxbridge Clinical.
Oxbridge Clinical's industry is
Biotechnology Research
Oxbridge Clinical's top competitors are
Tissuelabs,
Visicell Medical Inc.,
Gambitbio,
Full Circles Therapeutics Inc.,
Eukarÿs,
Ramona,
Nanovery,
Amptiv Biosciences,
Evoworks Bio,
Osem Fluidics.
Oxbridge Clinical's categories are Biotechnology Research
Oxbridge Clinical's founding year is 2023
